Skip to content

David Fischell

Chief Executive Officer at TETmedical.

Earliest Form D on file: Jun 2026

Filed Jun 24, 2026

TETmedical

Rapid blood test for ischemic stroke

Biotech, Fair Haven NJ

Signed as Chief Executive Officer

$3.5M

sold of $9.8M offered

Form D

LinkedIn

Network

At TETmedical

4 people